We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!! -- Ignore unavailable to you. Want to Upgrade?

To: Zencone who wrote (176)4/19/1999 4:33:00 PM
From: Cindy Powell  Read Replies (1) | Respond to of 196
You may be right, Baruch, but they are broadening their horizons with the hope for differing revenue producing products, which I think is good, because one never knows what new product is going to really catch on. I think that their scar products have a good chance of capturing market share and an looking forward to see what developes. I have seen several scar products (patches, rather than gels) advertised in the major magazines, and I would think that MLSC's gel approach would be far more desirable and functional. I think they are making steps in the right direction and putting their money where their mouth is. I am really excited to see that they are really going gangbusters with their research and toxicity studies. I think that this is tell-tale, and I also think that those scientists and others "in the know" that are closely involved with Medical Discoveries' technologies, see alot of potential with MDI-P and it's variations, and they are going to go for the gusto~ I will feel a little better when I see the company in a better financial position, but I think they are determined to make a go of this, and believe that "when there is a will there is a way." I'm still holding, and trying not to get too sea-sick with all the tape's ups and downs and to's and fro's. I may even consider buying more on these dips.

Best of luck,